NCT05834595

A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828

An Open-label, Randomized, Fasted, Single-dose, 2-sequence, 4-period, Replicate Crossover Study to Compare the Pharmacokinetic and Safety Between Administration of CKD-828 20/2.5mg and Administration of D064, D701 in Healthy Adults

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 43 (actual)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

A clinical trial to compare the pharmacokinetic and safety of CKD-828

Detailed description

An open-label, randomized, fasted, single-dose, 2-sequence, 4-period, replicate crossover study to compare the pharmacokinetic characteristics and safety between administration of CKD-828 20/2.5mg and administration of D064, D701 in healthy adults

Conditions

• Hypertension

Interventions

Type	Name	Description
DRUG	CKD-828, D064, D701	QD, PO

Timeline

• Start date: 2023-05-02
• Primary completion: 2023-07-18
• Completion: 2023-07-26
• First posted: 2023-04-28
• Last updated: 2023-08-25

Locations

1 site across 1 country: South Korea